Btk Antibody
Selleck Chemicals
SKU:F0426-20UL
Couldn't load pickup availability

About the Target
Bruton’s tyrosine kinase (BTK) is a non-receptor tyrosine kinase that plays a key role in oncogenic signaling essential for the proliferation and survival of leukemic cells in various B cell malignancies. As one of the five members of the TEC family of non-receptor tyrosine kinases, BTK shares similarities with TEC and ITK, with all three proteins containing five distinct interaction domains: an amino-terminal pleckstrin homology (PH) domain, a proline-rich TEC homology (TH) domain, SRC homology domains SH2 and SH3, and a kinase domain responsible for enzymatic activity.
Reported cellular context includes cell membrane, cytoplasm, membrane, and nucleus, which can matter when signal is compared across treatments or changing cell states. Following BTK across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.
Research Context
BTK is commonly interpreted in the context of cancer, developmental biology, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, cytoplasm, and membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.
Consider these angles when interpreting target-level changes:
- apparent redistribution between cell membrane, cytoplasm, and membrane across matched conditions
- changes associated with proliferative state, oncogenic signaling, or treatment response
- stage-dependent patterns during differentiation, morphogenesis, or lineage commitment
- signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
Variant Considerations
If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for BTK. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.
Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in BTK reflect biology rather than handling. When interpreting BTK, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.
For multi-run studies, a shared reference condition can keep BTK trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.
- Targets:
- BTK
- Research Area:
- Cancer • Cell Signaling • Developmental Biology
- Application:
- FCM • IHC • IP • WB
- Reactivity:
- Bovine • Dog • Hamster • Horse • Human • Mouse • Pig • Rat
- Specificity:
- Btk Antibody [M4L24] recognizes endogenous levels of total Btk protein.
- Host:
- Rabbit
- Clonality:
- Monoclonal
- Clone:
- M4L24
- UniProt:
- Q06187
- Storage Buffer:
- PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.